EspA is a novel fusion partner for expression of foreign proteins in Escherichia coli

Journal of Biotechnology

Volumn 150, Issue 3, 2010, Pages 380-388

  Cheng, Yan ^a   Gu, Jiang ^a   Wang, Hai guang ^a   Yu, Shu ^a   Liu, Yan qing ^a   Ning, Ya lei ^a   Zou, Quan ming ^a   Yu, Xue jie ^b   Mao, Xu hu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Escherichia coli; EspA; Fusion partner; Fusion protein

Indexed keywords

ANTI-TUMOR ACTIVITIES; C-TERMINUS; CLEAVAGE SITES; ESPA; EXPRESSION LEVELS; FUSION EXPRESSION; FUSION PARTNERS; FUSION PROTEINS; HIS-TAG; MULTIPLE CLONING; SECRETED PROTEIN; SECRETION SYSTEMS; TARGET PROTEINS;

AFFINITY CHROMATOGRAPHY; CLONING; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; MONOCLONAL ANTIBODIES; SOLUBILITY;

PROTEINS;

BACTERIAL PROTEIN; ESCHERICHIA COLI SECRETED PROTEIN A; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; INTERLEUKIN 24; INTIMIN; PROTEIN STX 2B; PROTEIN STX A1; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CARBOXY TERMINAL SEQUENCE; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

CELL LINE; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROPEPTIDASE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; INTERLEUKINS; RECOMBINANT FUSION PROTEINS; SOLUBILITY; THIOREDOXINS;

ESCHERICHIA COLI; EUKARYOTA; PROKARYOTA;

EID: 78149464373     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2010.09.940     Document Type: Article

References (40)

1. Anderluh G., Gokce I., Lakey J.H. Expression of proteins using the third domain of the Escherichia coli periplasmic-protein tola as a fusion partner. Protein Expr. Purif. 2003, 28:173-181.
2. Ashraf S.S., Benson R.E., Payne E.S., Halbleib C.M., Gron H. A novel multi-affinity tag system to produce high levels of soluble and biotinylated proteins in Escherichia coli. Protein Expr. Purif. 2004, 33:238-245.
3. Cao H., Dzineku F., Blackshear P.J. Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases. Arch. Biochem. Biophys. 2003, 412:106-120.
4. Chatterjee D.K., Esposito D. Enhanced soluble protein expression using two new fusion tags. Protein Expr. Purif. 2006, 46:122-129.
5. Cheng Y., Feng Y., Luo P., Gu J., Yu S., Zhang W.J., Liu Y.Q., Wang Q.X., Zou Q.M., Mao X.H. Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development. J. Microbiol. 2009, 47:498-505.
6. Crepin V.F., Shaw R., Abe C.M., Knutton S., Frankel G. Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion. J. Bacteriol. 2005, 187:2881-2889.
7. Davis G.D., Elisee C., Newham D.M., Harrison R.G. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng. 1999, 65:382-388.
8. De Marco V., Stier G., Blandin S., de Marco A. The solubility and stability of recombinant proteins are increased by their fusion to NusA. Biochem. Biophys. Res. Commun. 2004, 322:766-771.
9. DelProposto J., Majmudar C.Y., Smith J.L., Brown W.C. Mocr: a novel fusion tag for enhancing solubility that is compatible with structural biology applications. Protein Expr. Purif. 2009, 63:40-49.
10. Donnelly M.I., Zhou M., Millard C.S., Clancy S., Stols L., Eschenfeldt W.H., Collart F.R., Joachimiak A. An expression vector tailored for large-scale, high-throughput purification of recombinant proteins. Protein Expr. Purif. 2006, 47:446-454.
11. Douette P., Navet R., Gerkens P., Galleni M., Levy D., Sluse F.E. Escherichia coli fusion carrier proteins act as solubilizing agents for recombinant uncoupling protein 1 through interactions with groel. Biochem. Biophys. Res. Commun. 2005, 333:686-693.
12. Esposito D., Chatterjee D.K. Enhancement of soluble protein expression through the use of fusion tags. Curr. Opin. Biotechnol. 2006, 17:353-358.
13. Feng Y., Zheng F., Pan X., Sun W., Wang C., Dong Y., Ju A.P., Ge J., Liu D., Liu C., Yan J., Tang J., Gao G.F. Existence and characterization of allelic variants of sao, a newly identified surface protein from streptococcus suis. FEMS Microbiol. Lett. 2007, 275:80-88.
14. Gu J., Liu Y., Yu S., Wang H., Wang Q., Yi Y., Zhu F., Yu X.J., Zou Q., Mao X. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes Infect. 2009, 11:835-841.
15. Hammarstrom M., Hellgren N., van Den Berg S., Berglund H., Hard T. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Protein Sci. 2002, 11:313-321.
16. Kapust R.B., Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 1999, 8:1668-1674.
17. Karpman D., Bekassy Z.D., Sjogren A.C., Dubois M.S., Karmali M.A., Mascarenhas M., Jarvis K.G., Gansheroff L.J., O"Brien A.D., Arbus G.S., Kaper J.B. Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr. Nephrol. 2002, 17:201-211.
18. Kato T., Hamada D., Fukui T., Hayashi M., Honda T., Murooka Y., Yanagihara I. A pH-dependent conformational change in EspA, a component of the Escherichia coli O157:H7 type III secretion system. Febs J. 2005, 272:2773-2783.
19. Kuhne S.A., Hawes W.S., La Ragione R.M., Woodward M.J., Whitelam G.C., Gough K.C. Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7. J. Clin. Microbiol. 2004, 42:2966-2976.
20. LaVallie E.R., Lu Z., Diblasio-Smith E.A., Collins-Racie L.A., McCoy J.M. Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli. Methods Enzymol. 2000, 326:322-340.
21. Liew O.W., Ching Chong J.P., Yandle T.G., Brennan S.O. Preparation of recombinant thioredoxin fused N-terminal proCNP: analysis of enterokinase cleavage products reveals new enterokinase cleavage sites. Protein Expr. Purif. 2005, 41:332-340.
22. Liu L., Zeng H., Luo P., Wu J., Chen H., Shi Y., Zhang W., Mao X., Xiao B., Zou Q. Cloning a truncated fragment (stx2a(1)) of the shiga-like toxin 2a (1) subunit of EHEC O157:H7: candidate immunogen for a subunit vaccine. Mol. Biotechnol. 2009, 43:8-14.
23. Marblestone J.G., Edavettal S.C., Lim Y., Lim P., Zuo X., Butt T.R. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. Protein Sci. 2006, 15:182-189.
24. Nallamsetty S., Waugh D.S. Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners. Protein Expr. Purif. 2006, 45:175-182.
25. Pryor K.D., Leiting B. High-level expression of soluble protein in Escherichia coli using a his6-tag and maltose-binding-protein double-affinity fusion system. Protein Expr. Purif. 1997, 10:309-319.
26. Schlieker C., Bukau B., Mogk A. Prevention and reversion of protein aggregation by molecular chaperones in the E. coli cytosol: implications for their applicability in biotechnology. J. Biotechnol. 2002, 96:13-21.
27. Sekiya K., Ohishi M., Ogino T., Tamano K., Sasakawa C., Abe A. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11638-11643.
28. Singh M.P., Shaw R.K., Knutton S., Pallen M.J., Crepin V.F., Frankel G. Identification of amino acid residues within the N-terminal domain of EspA that play a role in EspA filament biogenesis and function. J. Bacteriol. 2008, 190:2221-2226.
29. Sorensen H.P., Sperling-Petersen H.U., Mortensen K.K. A favorable solubility partner for the recombinant expression of streptavidin. Protein Expr. Purif. 2003, 32:252-259.
30. Su Y., Zou Z., Feng S., Zhou P., Cao L. The acidity of protein fusion partners predominantly determines the efficacy to improve the solubility of the target proteins expressed in Escherichia coli. J. Biotechnol. 2007, 129:373-382.
31. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2003, 60:523-533.
32. Turner P., Holst O., Karlsson E.N. Optimized expression of soluble cyclomaltodextrinase of thermophilic origin in Escherichia coli by using a soluble fusion-tag and by tuning of inducer concentration. Protein Expr. Purif. 2005, 39:54-60.
33. Vasina J.A., Baneyx F. Expression of aggregation-prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspa and tac promoter systems. Protein Expr. Purif. 1997, 9:211-218.
34. Wilkinson D.L., Harrison R.G. Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (NY) 1991, 9:443-448.
35. Wojciechowski K., Chang C.H., Hocking D.C. Expression, production, and characterization of full-length vitronectin in Escherichia coli. Protein Expr. Purif. 2004, 36:131-138.
36. Xu X., Jin F., Yu X., Ren S., Hu J., Zhang W. High-level expression of the recombinant hybrid peptide cecropina(1-8)-magainin2(1-12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr. Purif. 2007, 55:175-182.
37. Yang J., Zhang W., Liu K., Jing S., Guo G., Luo P., Zou Q. Expression, purification, and characterization of recombinant human interleukin 24 in Escherichia coli. Protein Expr. Purif. 2007, 53:339-345.
38. Yasukawa T., Kanei-Ishii C., Maekawa T., Fujimoto J., Yamamoto T., Ishii S. Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J. Biol. Chem. 1995, 270:25328-25331.
39. Yin J., Lin J., Li W., Wang D.I. Evaluation of different promoters and host strains for the high-level expression of collagen-like polymer in Escherichia coli. J. Biotechnol. 2003, 100:181-191.
40. Zhang Y., Olsen D.R., Nguyen K.B., Olson P.S., Rhodes E.T., Mascarenhas D. Expression of eukaryotic proteins in soluble form in Escherichia coli. Protein Expr. Purif. 1998, 12:159-165.